ABUS

Arbutus Biopharma Stock Price

3.80
-0.57 (-13.04%)
Upgrade to Real-Time
Afterhours (Closed)
3.80
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Arbutus Biopharma Corporation ABUS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.57 -13.04% 3.80 3.43 4.04 3.88 4.37 00:00:00
Bid Price Ask Price Spread Spread % News
3.78 4.50 0.72 16.0% 4 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
34,710 11,335,198 $ 3.83 $ 43,370,364 15,981,759 0.81 - 9.00
Last Trade Time Type Quantity Stock Price Currency
19:58:45 32 $ 3.82 USD

Arbutus Biopharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 262.05M 68.96M 51.28M $ 6.01M $ - -2.89 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -20.00k 8.40%

more financials information »

Arbutus Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ABUS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.314.88533.434.085,614,798-0.51-11.83%
1 Month1.859.001.604.9121,973,0781.95105.41%
3 Months1.869.001.604.618,342,0611.94104.3%
6 Months3.209.000.884.314,251,7880.6018.75%
1 Year1.619.000.814.062,392,4452.19136.02%
3 Years3.4012.600.814.371,026,6800.4011.76%
5 Years9.9312.600.814.38710,997-6.13-61.73%

Arbutus Biopharma Description

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.


Your Recent History
NASDAQ
ABUS
Arbutus Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.